Alnylam Pharmaceuticals, Inc. News Headlines

Get ALNY Alerts
*Delayed - data as of Aug. 28, 2015  -  Find a broker to begin trading ALNY now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ALNY After Hours
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Filtered By
Ordered By

What Are IBB and XBI’s Valuations?
8/25/2015 9:17:00 AM - Market Realist

What Are IBB and XBI’s Valuations?
8/25/2015 8:12:00 AM - Market Realist

IBB Outperforms XBI: Top 10 Mid-Cap Stocks
8/21/2015 11:08:00 PM - Market Realist

What Are IBB and XBI’s Valuations?
8/20/2015 6:52:00 PM - Market Realist

IBB and XBI Underperformed the Benchmark Indexes
8/20/2015 6:51:00 PM - Market Realist

Alnylam Pharmaceuticals Underperformed: Fell by 16%
8/20/2015 10:06:00 AM - Market Realist

Regeneron Leads and Shire Dragged the Large-Cap Stocks
8/19/2015 9:07:00 AM - Market Realist

IBB Drops Out of the 50-Day and 20-Day Moving Averages
8/18/2015 2:56:00 PM - Market Realist

IBB Fell by 3.62% in the Week Ending August 7
8/18/2015 2:56:00 PM - Market Realist

Unpartnered Assets Face Waiting Game
8/18/2015 9:46:00 AM - Seeking Alpha

Alnylam initiates Phase 1/2 ALN-AAT trial in liver disease
7/27/2015 11:05:00 AM - Seeking Alpha

An Assessment Of Celgene's Deal For Receptos
7/21/2015 12:46:00 PM - Seeking Alpha